AXSOME THERAPEUTICS, INC. (AXSM) Shareholders’ equity 2022–2025
AXSOME THERAPEUTICS, INC. (AXSM) shareholders’ equity at each fiscal year-end, per SEC filings.
$88.3MFY2025 · since FY2022: $109.6M → $88.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $88.3M | +54.9% |
| FY2024 | $57.0M | -70.1% |
| FY2023 | $191.0M | +74.3% |
| FY2022 | $109.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice